These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25574168)

  • 1. Phosphoglycerate dehydrogenase: potential therapeutic target and putative metabolic oncogene.
    Zogg CK
    J Oncol; 2014; 2014():524101. PubMed ID: 25574168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of D-3-Phosphoglycerate Dehydrogenase in Cancer.
    Zhao X; Fu J; Du J; Xu W
    Int J Biol Sci; 2020; 16(9):1495-1506. PubMed ID: 32226297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.
    Li M; Wu C; Yang Y; Zheng M; Yu S; Wang J; Chen L; Li H
    Cell Oncol (Dordr); 2021 Jun; 44(3):541-556. PubMed ID: 33735398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into the enzymatic activity and potential substrate promiscuity of human 3-phosphoglycerate dehydrogenase (PHGDH).
    Unterlass JE; Wood RJ; Baslé A; Tucker J; Cano C; Noble MME; Curtin NJ
    Oncotarget; 2017 Nov; 8(61):104478-104491. PubMed ID: 29262655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective overview of PHGDH and its inhibitors for regulating cancer metabolism.
    Zhao JY; Feng KR; Wang F; Zhang JW; Cheng JF; Lin GQ; Gao D; Tian P
    Eur J Med Chem; 2021 May; 217():113379. PubMed ID: 33756126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer's sweet tooth for serine.
    Luo J
    Breast Cancer Res; 2011; 13(6):317. PubMed ID: 22189202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E.
    Ma X; Li B; Liu J; Fu Y; Luo Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):66. PubMed ID: 30744688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PHGDH amplification and altered glucose metabolism in human melanoma.
    Mullarky E; Mattaini KR; Vander Heiden MG; Cantley LC; Locasale JW
    Pigment Cell Melanoma Res; 2011 Dec; 24(6):1112-5. PubMed ID: 21981974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells.
    Mullarky E; Xu J; Robin AD; Huggins DJ; Jennings A; Noguchi N; Olland A; Lakshminarasimhan D; Miller M; Tomita D; Michino M; Su T; Zhang G; Stamford AW; Meinke PT; Kargman S; Cantley LC
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2503-2510. PubMed ID: 31327531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine Synthesis Helps Hypoxic Cancer Stem Cells Regulate Redox.
    Samanta D; Semenza GL
    Cancer Res; 2016 Nov; 76(22):6458-6462. PubMed ID: 27811150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Phosphoglycerate Transhydrogenation Instead of Dehydrogenation Alleviates the Redox State Dependency of Yeast de Novo l-Serine Synthesis.
    Paczia N; Becker-Kettern J; Conrotte JF; Cifuente JO; Guerin ME; Linster CL
    Biochemistry; 2019 Jan; 58(4):259-275. PubMed ID: 30668112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer.
    Xian Y; Zhang S; Wang X; Qin J; Wang W; Wu H
    Onco Targets Ther; 2016; 9():5553-60. PubMed ID: 27660473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Activity Relationships (SARs) of α-Ketothioamides as Inhibitors of Phosphoglycerate Dehydrogenase (PHGDH).
    Spillier Q; Ravez S; Unterlass J; Corbet C; Degavre C; Feron O; Frédérick R
    Pharmaceuticals (Basel); 2020 Jan; 13(2):. PubMed ID: 31979167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profiling.
    Chen C; Zhu T; Liu X; Zhu D; Zhang Y; Wu S; Han C; Zhang H; Luo J; Kong L
    Acta Pharm Sin B; 2022 Jan; 12(1):246-261. PubMed ID: 35127383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoglycerate dehydrogenase inhibition induces p-mTOR-independent autophagy and promotes multilineage differentiation in embryonal carcinoma stem-like cells.
    Sharif T; Martell E; Dai C; Ghassemi-Rad MS; Lee K; Singh SK; Weaver ICG; Gujar S
    Cell Death Dis; 2018 Sep; 9(10):990. PubMed ID: 30250195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PHGDH as a mechanism for resistance in metabolically-driven cancers.
    Rathore R; Schutt CR; Van Tine BA
    Cancer Drug Resist; 2020; 3(4):762-774. PubMed ID: 33511334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ixocarpalactone A from dietary tomatillo inhibits pancreatic cancer growth by targeting PHGDH.
    Zheng M; Guo J; Xu J; Yang K; Tang R; Gu X; Li H; Chen L
    Food Funct; 2019 Jun; 10(6):3386-3395. PubMed ID: 31112178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers.
    Mullarky E; Lucki NC; Beheshti Zavareh R; Anglin JL; Gomes AP; Nicolay BN; Wong JC; Christen S; Takahashi H; Singh PK; Blenis J; Warren JD; Fendt SM; Asara JM; DeNicola GM; Lyssiotis CA; Lairson LL; Cantley LC
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1778-83. PubMed ID: 26831078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validating and enabling phosphoglycerate dehydrogenase (PHGDH) as a target for fragment-based drug discovery in PHGDH-amplified breast cancer.
    Unterlass JE; Baslé A; Blackburn TJ; Tucker J; Cano C; Noble MEM; Curtin NJ
    Oncotarget; 2018 Mar; 9(17):13139-13153. PubMed ID: 29568346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity.
    Wang Q; Liberti MV; Liu P; Deng X; Liu Y; Locasale JW; Lai L
    Cell Chem Biol; 2017 Jan; 24(1):55-65. PubMed ID: 28042046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.